[2003 update of the Guidelines of the Spanish Society of Cardiology on High Blood Pressure].
Since publication of the Spanish Society of Cardiology Clinical Practice Guidelines on High Blood Pressure in January 2000, a new body of scientific evidence has been obtained that needs to be taken into account in clinical practice. A complete clinical evaluation by assessment of the global cardiovascular risk score should be done in patients with hypertension. In this connection, ECG findings and urine albumin excretion are of particular value. Up to now, the results of most important clinical trials indicate that the aim should be to normalize blood pressure, with stricter control in patients at higher risk (diabetes, target organ damage or left ventricular hypertrophy). Antihypertensive therapy should be selected on an individual basis, taking in account that patients with certain associated pathologies will benefit more from particular groups of drugs. Those with diabetes or left ventricular hypertrophy seem to benefit from pharmacological block of the renin-angiotensin system, and patients with heart failure from combined therapy with ACE inhibitors plus beta-blockers.
Sección de Hipertensión Arterial de la Sociedad Española de Cardiología. Madrid. España. jose.ramon.gonzalez.juanatey@sergas.es
José Ramón
JR
González-Juanatey
Pilar
P
Mazón Ramos
Federico
F
Soria Arcos
Vivencio
V
Barrios Alonso
Luis
L
Rodríguez Padial
Vicente
V
Bertomeu Martínez
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006977:Hypertension, Renal / Q000150:complications / Q000503:physiopathology; D008297:Male; D011247:Pregnancy; D012307:Risk Factors; D009626:Terminology as Topic
D000959:Antihypertensive Agents